Radebeul, Germany

Eberhard Schubert

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Arzneimittelwerk Dresden Gmbh. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eberhard Schubert. Retrieved from https://idiyas.com/inventor/eberhard-schubert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Eberhard Schubert

Introduction

Eberhard Schubert is a notable inventor based in Radebeul, Germany, renowned for his contributions to the pharmaceutical industry. With a focus on enhancing drug delivery methods, Schubert has demonstrated a dedicated commitment to innovation in medicine.

Latest Patents

Schubert holds a patent for a medicament of carbamazepine featuring a retarded active substance release. This innovative approach aims to improve the therapeutic efficacy and patient compliance of carbamazepine, a medication primarily used for treating epilepsy and bipolar disorder.

Career Highlights

Throughout his career, Eberhard Schubert has been associated with Arzneimittelwerk Dresden GmbH, where he has played a pivotal role in pharmaceutical developments. His work within the company underscores his expertise and dedication to advancing medicinal technologies.

Collaborations

Schubert has collaborated with esteemed colleagues such as Karl-Friedrich Landgraf and Sabine Reiss. Together, they have contributed to meaningful advancements in the pharmaceutical sector, reflecting a strong spirit of teamwork and innovation.

Conclusion

Eberhard Schubert stands out as a committed inventor contributing valuable innovations to medicine. His patent, designed to enhance the efficacy of carbamazepine, showcases his ability to tackle complex challenges in drug development. With continued collaboration and dedication, Schubert is likely to make further significant impacts in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…